Stay updated with breaking news from Side Effect Correlation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Robert Mancini, PharmD, discusses bispecific therapy advancements and strategies to manage adverse effects in diffuse large B-cell lymphoma (DLBCL) care, offering insights on toxicity phases, monitoring, and patient care.
Health care experts provide insights into patient education, shared decision-making, and treatment monitoring in DLBCL (diffuse large B cell lymphoma) therapies, reviewing education strategies and response monitoring.